Stay updated on Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version number, changing from v2.15.0 to v2.15.2, and the phrasing regarding the last update has been clarified.
    Difference
    0.1%
    Check dated 2025-04-30T14:25:42.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new phase 2 study involving Ipilimumab and Nivolumab for treating HPV-positive oropharyngeal carcinoma, with a new estimated last update date of April 2025.
    Difference
    2%
    Check dated 2025-04-23T13:47:41.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of detailed clinical stages and types of HPV-mediated oropharyngeal carcinoma, as well as the inclusion of a quality-of-life assessment and a new registry identifier. However, extensive information regarding the study's objectives, treatment protocols, and inclusion/exclusion criteria has been removed.
    Difference
    53%
    Check dated 2025-04-16T10:52:10.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T05:23:59.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:31:50.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:19:17.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.